FGF21 Is an Exocrine Pancreas Secretagogue

Slides:



Advertisements
Similar presentations
Volume 14, Issue 2, Pages (August 2011)
Advertisements

Volume 54, Issue 4, Pages (May 2014)
Li Ding, Lingling Han, Yin Li, Jing Zhao, Ping He, Weizhen Zhang 
Figure 1 Body weight of control and BPA-treated mothers after delivery
Volume 10, Issue 4, Pages (October 2009)
Volume 14, Issue 6, Pages (December 2011)
Volume 2, Issue 4, Pages (October 2005)
Volume 18, Issue 3, Pages (September 2013)
Volume 153, Issue 6, Pages (December 2017)
Volume 137, Issue 3, Pages e3 (September 2009)
Volume 26, Issue 2, Pages e3 (August 2017)
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Volume 17, Issue 4, Pages (April 2013)
Volume 20, Issue 6, Pages (December 2014)
Volume 10, Issue 4, Pages (October 2009)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Pancreatic acinar cell dysfunction in CFTR−/− mice is associated with impairments in luminal pH and endocytosis  Steven D. Freedman, Horst F. Kern, George.
Volume 8, Issue 1, Pages (January 2017)
Volume 23, Issue 5, Pages (May 2016)
IRS1-Independent Defects Define Major Nodes of Insulin Resistance
Histamine Contributes to Tissue Remodeling via Periostin Expression
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 134, Issue 3, Pages (March 2008)
Volume 15, Issue 5, Pages (May 2012)
Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells  Katarzyna M. Skrzypczynska, Jing W. Zhu,
Volume 18, Issue 6, Pages (December 2013)
FGF21 Regulates Sweet and Alcohol Preference
Volume 23, Issue 2, Pages (February 2016)
Volume 18, Issue 13, Pages (March 2017)
Volume 11, Issue 4, Pages (April 2010)
Qinglan Zhao, Yi Wei, Stephen J. Pandol, Lingyin Li, Aida Habtezion 
Volume 19, Issue 2, Pages (February 2014)
Volume 9, Issue 6, Pages (June 2009)
Volume 129, Issue 2, Pages (August 2005)
Volume 29, Issue 5, Pages (March 2008)
Volume 1, Issue 2, Pages (February 2005)
Volume 7, Issue 2, Pages (February 2008)
Heat Shock Transcription Factor 1 Is a Key Determinant of HCC Development by Regulating Hepatic Steatosis and Metabolic Syndrome  Xiongjie Jin, Demetrius.
Volume 9, Issue 5, Pages (May 2009)
Volume 137, Issue 5, Pages (November 2009)
Volume 16, Issue 2, Pages (August 2012)
Volume 10, Issue 1, Pages (July 2009)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 14, Issue 1, Pages (July 2011)
Volume 7, Issue 1, Pages (January 2008)
Volume 122, Issue 2, Pages (July 2005)
Volume 6, Issue 5, Pages (November 2007)
Volume 14, Issue 4, Pages (October 2011)
Volume 6, Issue 3, Pages (September 2007)
Volume 15, Issue 2, Pages (February 2014)
Volume 14, Issue 2, Pages (August 2011)
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 22, Issue 6, Pages (February 2018)
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 129, Issue 2, Pages (April 2007)
Volume 51, Issue 4, Pages (August 2006)
Volume 16, Issue 4, Pages (October 2012)
Volume 20, Issue 4, Pages (October 2014)
Volume 6, Issue 4, Pages (October 2007)
Volume 26, Issue 5, Pages e3 (November 2017)
Joan Goulley, Ulf Dahl, Nathalie Baeza, Yuji Mishina, Helena Edlund 
A Novel Role for Bcl-2 in Regulation of Cellular Calcium Extrusion
Volume 128, Issue 3, Pages (March 2005)
Volume 24, Issue 1, Pages (July 2018)
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Volume 156, Issue 4, Pages (February 2014)
The GCN2 eIF2α Kinase Regulates Fatty-Acid Homeostasis in the Liver during Deprivation of an Essential Amino Acid  Feifan Guo, Douglas R. Cavener  Cell.
Zhiyu Wang, Nathaniel W. York, Colin G. Nichols, Maria S. Remedi 
Volume 16, Issue 3, Pages (September 2012)
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

FGF21 Is an Exocrine Pancreas Secretagogue Katie C. Coate, Genaro Hernandez, Curtis A. Thorne, Shengyi Sun, Thao D.V. Le, Kevin Vale, Steven A. Kliewer, David J. Mangelsdorf  Cell Metabolism  Volume 25, Issue 2, Pages 472-480 (February 2017) DOI: 10.1016/j.cmet.2016.12.004 Copyright © 2017 Elsevier Inc. Terms and Conditions

Cell Metabolism 2017 25, 472-480DOI: (10.1016/j.cmet.2016.12.004) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 Pancreatic FGF21 Regulates Digestive Enzyme Levels (A and B) Immunofluorescence for amylase (green) and nuclei (blue) (A) and western blot quantification of amylase and lipase levels (B) in wild-type (WT) and Fgf21 knockout (KO) mice after an overnight fast and 2 hr refeeding period. Calibration bar, 20 μm. (C and D) Immunofluorescence for amylase (green) and nuclei (blue) (C) and western blot quantification of amylase and lipase levels (D) in WT and Fgf21 KO mice treated with vehicle or 1 mg/kg recombinant FGF21 twice per day for 2 consecutive days. Calibration bar, 20 μm. (E–G) Pancreatic FGF21 mRNA (E), pancreatic FGF21 protein (F), and plasma FGF21 (G) levels in WT mice after an overnight fast and 2 hr refeeding period. (H) FGF21 protein levels in pancreatic juice and plasma before (Basal) or after 15 min CCK treatment of ad lib fed WT mice. Results are expressed as means ± SEM; n = 3–6 mice/group for all experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001. See also Figure S1. Cell Metabolism 2017 25, 472-480DOI: (10.1016/j.cmet.2016.12.004) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 FGF21 Attenuates ER Stress during Cerulein-Induced Pancreatitis (A and B) Quantification of phospho (p)-eIF2α protein (western blot image is shown at right) and Atf4, Chop, Bip, and XBP1s mRNA analyzed by qPCR in wild-type (WT) and Fgf21 knockout (KO) mice (A) or WT and Fgf21-transgenic (Tg) mice (B) treated with cerulein to induce pancreatitis (CIP). Results are expressed as means ± SEM; n = 3–6 mice/group for all experiments. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001. Cell Metabolism 2017 25, 472-480DOI: (10.1016/j.cmet.2016.12.004) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 FGF21 Acts on Acinar Cells to Induce Pancreatic Digestive Enzyme Secretion without Affecting Protein Synthesis (A and B) 3H-Phenylalanine incorporation into pancreatic protein (A) and western blot quantification of pancreatic phospho (p)-eIF4E-BP1 and p-ERK1/2 (B) in mice treated with vehicle, 1 mg/kg FGF21, or 5 μg/kg CCK for 2 hr (A) or 15 min (B). (C–F) Pancreatic juice flow rates and amylase levels in the pancreatic juice of WT mice (C and D) or heterozygous (Het) control or β-Klotho knockout (KO) mice (E and F) treated with vehicle or 1 mg/kg FGF21 for 2 consecutive days. (G and H) Amylase secretion from mouse primary acinar cells (G) and AR42J cells (H) treated with vehicle, 1 μg/mL FGF21, 10 pM (primary acinar cells), 100 pM (AR42J cells) CCK, or both 1 μg/mL FGF21 and 10 pM CCK (primary acinar cells) for 30 min. (I and J) Amylase levels (I) and pancreatic juice flow rates (J) in the pancreatic juice of Klbfl/fl and KlbCela1−/− mice treated with vehicle or 1 mg/kg FGF21 for 2 consecutive days. Results are expressed as means ± SEM; n = 4–6 mice/group for all experiments. Primary acinar cell experiments were performed in triplicate, and similar results were obtained in three independent experiments.∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001; ∗∗∗∗p < 0.0001. See also Figures S2 and S3. Cell Metabolism 2017 25, 472-480DOI: (10.1016/j.cmet.2016.12.004) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 4 FGF21 Triggers Intracellular Calcium Release via an FGFR-PLC-IP3R Pathway (A–E) Calcium release in AR42J cells was measured by the calcium indicator Fluo4-AM signal minus background fluorescence normalized to baseline fluorescence (ΔF/F0) for 2 min at 10× magnification. Cells were imaged for 10 s and then treated with either 1 μg/mL FGF21 (left panels) or 100 pM CCK (right panels). Black arrows indicate the start of treatment. In (B)–(E), cells were treated 30 min prior and during imaging with 1 μM PD173074 (B), 10 μM L-364,718 (C), 10 μM U73122 (D), or 100 μM 2-APB (E). Calcium transients are expressed as the mean calcium release of 50–200 cell clusters/group with each cluster containing 5–20 cells. Similar results were obtained in two independent experiments. (F) Western blot images and quantification of pancreatic total (T) and phospho (p) PLCγ1 and PLCβ3 and p-ERK1/2 from WT mice treated with 1 mg/kg FGF21 or 5 μg/kg CCK (i.p.) for 15 min. Hsp90 is the loading control. Results are expressed as means ± SEM n = 4 mice/group. ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001. (G) Model for the action of FGF21 on the acinar cell to stimulate digestive enzyme secretion. See also Figure S4. Cell Metabolism 2017 25, 472-480DOI: (10.1016/j.cmet.2016.12.004) Copyright © 2017 Elsevier Inc. Terms and Conditions